Australian biotech boosted by Aus$200m VC fund
This article was originally published in Scrip
Executive Summary
Brandon Capital, an Australian venture capital firm, has closed its third Medical Research Commercialisation Fund (MRCF), raising Aus$200m (around US$155m) and marking the country's largest ever life sciences-focused VC fundraising.